FDA to sidestep advisers on approval for expanding COVID booster shot eligibility

WASHINGTON — The Food and Drug Administration's committee of outside experts is not planning to meet to discuss the data on Pfizer's request for authorization of boosters-for-all, which federal officials are expected to greenlight this week, ...

from Google Alert - Business https://ift.tt/3wURvvn
WASHINGTON — The Food and Drug Administration's committee of outside experts is not planning to meet to discuss the data on Pfizer's request for authorization of boosters-for-all, which federal officials are expected to greenlight this week, ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize